Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Aug;15(8):437.
doi: 10.1038/s41574-019-0233-3.

Teplizumab delays onset of type 1 diabetes mellitus

Alan Morris  1
Affiliations
Comment

Teplizumab delays onset of type 1 diabetes mellitus

Alan Morris. Nat Rev Endocrinol. 2019 Aug.
No abstract available

PubMed Disclaimer

Comment on

  • An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
    Herold KC, Bundy BN, Long SA, Bluestone JA, DiMeglio LA, Dufort MJ, Gitelman SE, Gottlieb PA, Krischer JP, Linsley PS, Marks JB, Moore W, Moran A, Rodriguez H, Russell WE, Schatz D, Skyler JS, Tsalikian E, Wherrett DK, Ziegler AG, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group. Herold KC, et al. N Engl J Med. 2019 Aug 15;381(7):603-613. doi: 10.1056/NEJMoa1902226. Epub 2019 Jun 9. N Engl J Med. 2019. PMID: 31180194 Free PMC article. Clinical Trial.

References

Original article
    1. Herold, K. C. et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa1902226 (2019) - DOI - PubMed

Substances

LinkOut - more resources